Back to trial details

Intake questionnaire

Semaglutide Delivered Epi-Intradermally by Microarray Patch (VX-201) Versus Subcutaneous Administration in Healthy Overweight and Obese Participants

Applying to Celerion Clinical Research · Tempe, Arizona

Answer a few short questions to share with the research team.

0 of 3 answered

1. Are you between 18 and 60 years old?
2. Have you been diagnosed with Overweight and/or Obesity?
3. Are you able to travel to Tempe for study visits?